Assignee
RENOTARGET THERAPEUTICS INC
US·1 granted patent·1 pending application·0 citations·filing 2017–2019
Top patents by PatentIndex Score
2 records- 0131US10202357B2Class of quinolone heterocyclic aromatic molecules for cancer treatmentRENOTARGET THERAPEUTICS INC·Filed 2017·Granted Feb 12, 2019·0 cites·14 claims
- 0228US2019169134A1Novel class of quinolone heterocyclic aromatic molecules for cancer treatmentRENOTARGET THERAPEUTICS INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when RENOTARGET THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →